Efficacy and Safety of Ofatumumab Retreatment and Maintenance Treatment in Patients With B-cell Chronic Lymphocytic Leukemia (CLL)

Clinical trial NCT00802737 · COMPLETED

Trial details

NCT number: NCT00802737
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Leukaemia, Lymphocytic, Chronic

Start date: 2009-01-01
Primary completion: 2011-09-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.